Gofen & Glossberg’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.5M | Buy |
45,004
+8,205
| +22% | +$665K | 0.09% | 160 |
|
|
2022
Q3 | $2.97M | Buy |
36,799
+2,559
| +7% | +$230K | 0.08% | 167 |
|
|
2022
Q2 | $3.07M | Buy |
34,240
+6,615
| +24% | +$670K | 0.08% | 169 |
|
|
2022
Q1 | $3.06M | Buy |
27,625
+1,576
| +6% | +$167K | 0.07% | 174 |
|
|
2021
Q4 | $2.69M | Buy |
26,049
+5,427
| +26% | +$628K | 0.06% | 179 |
|
|
2021
Q3 | $2.58M | Buy |
20,622
+1,068
| +5% | +$138K | 0.06% | 183 |
|
|
2021
Q2 | $2.43M | Buy |
19,554
+312
| +2% | +$39.2K | 0.06% | 182 |
|
|
2021
Q1 | $2.27M | Buy |
19,242
+3,164
| +20% | +$371K | 0.06% | 176 |
|
|
2020
Q4 | $1.88M | Buy |
16,078
+166
| +1% | +$18.3K | 0.05% | 182 |
|
|
2020
Q3 | $1.65M | Buy |
15,912
+3,328
| +26% | +$334K | 0.05% | 177 |
|
|
2020
Q2 | $1.15M | Buy |
12,584
+2,519
| +25% | +$242K | 0.04% | 193 |
|
|
2020
Q1 | $908K | Buy |
10,065
+125
| +1% | +$13.3K | 0.04% | 201 |
|
|
2019
Q4 | $1.13M | Buy |
9,940
+1,271
| +15% | +$139K | 0.04% | 205 |
|
|
2019
Q3 | $942K | Buy |
8,669
+788
| +10% | +$82.2K | 0.03% | 218 |
|
|
2019
Q2 | $768K | Sell |
7,881
-385
| -5% | -$35.2K | 0.03% | 228 |
|
|
2019
Q1 | $753K | Buy |
8,266
+1,560
| +23% | +$140K | 0.03% | 224 |
|
|
2018
Q4 | $610K | Buy |
6,706
+73
| +1% | +$6.82K | 0.02% | 237 |
|
|
2018
Q3 | $652K | Sell |
6,633
-1,452
| -18% | -$134K | 0.02% | 248 |
|
|
2018
Q2 | $692K | Sell |
8,085
-55
| -0.7% | -$4.59K | 0.03% | 235 |
|
|
2018
Q1 | $653K | Buy |
8,140
+301
| +4% | +$24.8K | 0.02% | 247 |
|
|
2017
Q4 | $633K | Buy |
7,839
+240
| +3% | +$19.2K | 0.02% | 259 |
|
|
2017
Q3 | $591K | Buy |
7,599
+642
| +9% | +$53.3K | 0.02% | 267 |
|
|
2017
Q2 | $617K | Buy |
6,957
+100
| +1% | +$8.43K | 0.02% | 263 |
|
|
2017
Q1 | $552K | Sell |
6,857
-3,730
| -35% | -$291K | 0.02% | 273 |
|
|
2016
Q4 | $754K | Buy |
10,587
+30
| +0.3% | +$2.36K | 0.03% | 236 |
|
|
2016
Q3 | $912K | Sell |
10,557
-192
| -2% | -$16.7K | 0.04% | 213 |
|
|
2016
Q2 | $933K | Sell |
10,749
-979
| -8% | -$79.2K | 0.04% | 209 |
|
|
2016
Q1 | $880K | Sell |
11,728
-679
| -5% | -$51.1K | 0.04% | 212 |
|
|
2015
Q4 | $954K | Buy |
12,407
+942
| +8% | +$70.9K | 0.04% | 203 |
|
|
2015
Q3 | $767K | Sell |
11,465
-201
| -2% | -$14.8K | 0.03% | 228 |
|
|
2015
Q2 | $864K | Sell |
11,666
-3,635
| -24% | -$278K | 0.04% | 221 |
|
|
2015
Q1 | $1.19M | Buy |
15,301
+5,225
| +52% | +$396K | 0.05% | 201 |
|
|
2014
Q4 | $727K | Sell |
10,076
-47
| -0.5% | -$3.27K | 0.03% | 238 |
|
|
2014
Q3 | $627K | Hold |
10,123
| – | – | 0.03% | 245 |
|
|
2014
Q2 | $645K | Sell |
10,123
-355
| -3% | -$21.6K | 0.03% | 237 |
|
|
2014
Q1 | $621K | Buy |
10,478
+1,076
| +11% | +$62.7K | 0.03% | 237 |
|
|
2013
Q4 | $540K | Sell |
9,402
-125
| -1% | -$7.09K | 0.03% | 252 |
|
|
2013
Q3 | $507K | Sell |
9,527
-900
| -9% | -$48.4K | 0.03% | 245 |
|
|
2013
Q2 | $537K | Buy |
+10,427
| New | +$515K | 0.03% | 229 |
|
Other funds holding MDT
Gofen & Glossberg's MDT Position: Q4 2022 in Review
Gofen & Glossberg increased its Medtronic (MDT) stake by 22% in Q4 2022, buying an estimated $665K and bringing the position to 45,004 shares worth $3.5M. The position accounts for 0.09% of the portfolio, ranked #160.
Gofen & Glossberg first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.
- Gofen & Glossberg held 45,004 shares of Medtronic worth $3.5M as of Q4 2022.
- Gofen & Glossberg bought 8,205 Medtronic shares in Q4 2022, an estimated $665K.
- Medtronic made up 0.09% of Gofen & Glossberg's portfolio in Q4 2022, its #160 holding.
- Gofen & Glossberg first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
- 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.